sotalol has been researched along with Atrioventricular Nodal Reentrant Tachycardia in 12 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
Excerpt | Relevance | Reference |
---|---|---|
"Our objective was to evaluate the efficacy and safety of intravenous (IV) sotalol in the treatment of incessant tachyarrhythmias in children with normal cardiac function." | 7.85 | Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children. ( Ge, H; Jiang, H; Li, X; Liu, H; Zhang, Y, 2017) |
"Both sotalol and ibutilide terminate atrial flutter in this model." | 7.69 | Antiarrhythmic and electrophysiologic effects of intravenous ibutilide and sotalol in the canine sterile pericarditis model. ( Brunden, MN; Buchanan, LV; Gibson, JK; Hsu, CY; LeMay, RJ; Walters, RR, 1996) |
"Our objective was to evaluate the efficacy and safety of intravenous (IV) sotalol in the treatment of incessant tachyarrhythmias in children with normal cardiac function." | 3.85 | Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children. ( Ge, H; Jiang, H; Li, X; Liu, H; Zhang, Y, 2017) |
"Both sotalol and ibutilide terminate atrial flutter in this model." | 3.69 | Antiarrhythmic and electrophysiologic effects of intravenous ibutilide and sotalol in the canine sterile pericarditis model. ( Brunden, MN; Buchanan, LV; Gibson, JK; Hsu, CY; LeMay, RJ; Walters, RR, 1996) |
"6 mg/kg sotalol, a beta-blocking agent with additional class III properties, were studied by means of electrophysiologic techniques in 14 patients, seven with the Wolff-Parkinson-White syndrome and seven with concealed atrioventricular (AV) accessory pathways." | 3.67 | Effects of intravenous sotalol in patients with atrioventricular accessory pathways. ( Atallah, G; Dellinger, A; Kirkorian, G; Lavaud, P; Mathieu, MP; Touboul, P, 1987) |
" Little justification for the use of agents or dosing in children is available." | 2.40 | Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry. ( Kuhn, RJ; Luedtke, SA; McCaffrey, FM, 1997) |
"Inappropriate sinus tachycardia was only observed after fast pathway ablation." | 1.29 | Inappropriate sinus tachycardia following radiofrequency ablation of AV nodal tachycardia: incidence and clinical significance. ( Andries, E; Brugada, P; Celiker, A; Simonis, F; Skeberis, V; Tsakonas, K, 1994) |
"Sotalol was administered to 32 patients with a mean age of 8." | 1.29 | [Results of oral sotalol therapy in children with supraventricular and ventricular arrhythmias]. ( Kallfelz, HC; Lehmann, C; Paul, T; Pfammatter, JP, 1994) |
"Sotalol is an antiarrhythmic medication that has properties of both a beta-blocker and a class III agent and has been used safely and effectively to treat arrhythmias of multiple mechanisms in pediatric patients." | 1.29 | Sotalol for refractory arrhythmias in pediatric and young adult patients: initial efficacy and long-term outcome. ( Lulu, JA; Saul, JP; Tanel, RE; Walsh, EP, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (8.33) | 18.7374 |
1990's | 10 (83.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (8.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, X | 1 |
Zhang, Y | 2 |
Liu, H | 1 |
Jiang, H | 1 |
Ge, H | 1 |
Skeberis, V | 1 |
Simonis, F | 1 |
Tsakonas, K | 1 |
Celiker, A | 1 |
Andries, E | 1 |
Brugada, P | 1 |
Paul, T | 1 |
Lehmann, C | 1 |
Pfammatter, JP | 1 |
Kallfelz, HC | 1 |
Tanel, RE | 1 |
Walsh, EP | 1 |
Lulu, JA | 1 |
Saul, JP | 1 |
Daubert, C | 1 |
Mabo, P | 1 |
Gras, D | 1 |
Leclercq, C | 1 |
Gutiérrez-Larraya, F | 1 |
Jabón, A | 1 |
Buchanan, LV | 1 |
LeMay, RJ | 1 |
Walters, RR | 1 |
Hsu, CY | 1 |
Brunden, MN | 1 |
Gibson, JK | 1 |
Luedtke, SA | 1 |
Kuhn, RJ | 1 |
McCaffrey, FM | 1 |
Haverkamp, W | 1 |
Hördt, M | 1 |
Breithardt, G | 1 |
Borggrefe, M | 1 |
Yu, WC | 1 |
Chen, SA | 1 |
Tai, CT | 1 |
Wen, ZC | 1 |
Feng, AN | 1 |
Ding, YA | 1 |
Chang, MS | 1 |
Millar, RN | 1 |
Touboul, P | 1 |
Atallah, G | 1 |
Kirkorian, G | 1 |
Lavaud, P | 1 |
Mathieu, MP | 1 |
Dellinger, A | 1 |
3 reviews available for sotalol and Atrioventricular Nodal Reentrant Tachycardia
Article | Year |
---|---|
Clinical role of d-sotalol and d,l-sotalol in supraventricular arrhythmias, including pre-excitation.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Humans; | 1993 |
[Tachycardias: considerations in childhood in the 90s].
Topics: Adenosine; Adolescent; Adult; Amiodarone; Atrial Flutter; Child; Child, Preschool; Electrocardiograp | 1993 |
Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Calcium Channel Blockers; Child; Ch | 1997 |
1 trial available for sotalol and Atrioventricular Nodal Reentrant Tachycardia
Article | Year |
---|---|
Efficacy of sotalol in controlling reentrant supraventricular tachycardias.
Topics: Adolescent; Adult; Aged; Electrocardiography; Female; Humans; Male; Middle Aged; Sotalol; Tachycardi | 1990 |
8 other studies available for sotalol and Atrioventricular Nodal Reentrant Tachycardia
Article | Year |
---|---|
Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children.
Topics: Adolescent; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Child; Child, Preschool; Dr | 2017 |
Inappropriate sinus tachycardia following radiofrequency ablation of AV nodal tachycardia: incidence and clinical significance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Atrioventricular Node; Catheter Ablation; Child; Electro | 1994 |
[Results of oral sotalol therapy in children with supraventricular and ventricular arrhythmias].
Topics: Administration, Oral; Adolescent; Adult; Atrial Flutter; Atrioventricular Node; Cardiac Complexes, P | 1994 |
Sotalol for refractory arrhythmias in pediatric and young adult patients: initial efficacy and long-term outcome.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Child; Child, Preschool; Female; Heart Conduction System; | 1995 |
Antiarrhythmic and electrophysiologic effects of intravenous ibutilide and sotalol in the canine sterile pericarditis model.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Flutter; Cross-Over Studies; Dogs; Electrocardiography; Infu | 1996 |
Torsade de pointes secondary to d,l-sotalol after catheter ablation of incessant atrioventricular reentrant tachycardia--evidence for a significant contribution of the "cardiac memory".
Topics: Administration, Oral; Anti-Arrhythmia Agents; Catheter Ablation; Electric Countershock; Electrocardi | 1998 |
Effects of procainamide and dl-sotalol on the changes of atrial electrophysiology induced by high current stimulation.
Topics: Adult; Aged; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Function; Atrial Premature Complex | 1998 |
Effects of intravenous sotalol in patients with atrioventricular accessory pathways.
Topics: Adolescent; Adult; Aged; Female; Heart Conduction System; Humans; Injections, Intravenous; Male; Mid | 1987 |